Pulse modulation in En-Bloc HoLEP: does it really matter? A propensity score matched analysis
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-04830-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Friedrich Otto Hartung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Urologic Surgery, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, G…. Hauptthemen laut MEDLINE: Lasers, Solid-State, Prostatic Hyperplasia, Transurethral Resection of Prostate, Laser Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Fakultät Mannheim der Universität Heidelberg.
Abstract (Originalsprache)
Introduction
Holmium laser enucleation of the prostate (HoLEP) is an established option in the surgical treatment of benign prostatic hyperplasia. Pulse modulation, such as MOSES® technology, has recently been introduced and may offer potential advantages in HoLEP.
Methods
Perioperative data from 117 patients who underwent MOSES® laser enucleation of the prostate (MoLEP) were collected. Propensity score matching using prostate volume, age, body mass index (BMI), and anticoagulant intake was performed using a database of 237 patients treated with HoLEP. In total, 234 patients were included in the analysis.
Results
Prostate volume (104 vs. 102 ml), age (70 vs. 71 years), BMI (27 vs. 27), and anticoagulant intake (34 vs. 35%) did not differ significantly between the groups. There were no significant differences in operation time (61.5 vs. 58.1 min, p = 0.42), enucleation efficiency (2.5 vs. 2.6 g/min, p = 0.74), hemostasis time (7.8 vs. 8 min, p = 0.75) and hemoglobin drop (0.9 vs. 0.7 mg/dl, p = 0.48). The complication rates were low in both groups (16.2% for HoLEP and 17.1% for MoLEP). No differences were noted in the Clavien-Dindo Classification (p = 0.63) and the Comprehensive Complication Index (p = 0.24). The rate of complications > CDC IIIa was 0.9% for HoLEP (endoscopic coagulation) and 1.7% for MoLEP (2 cases of endoscopic coagulation). No transfusions were administered.
Conclusion
Overall, the enucleation efficiency was high in both groups and the procedure time was short. HoLEP is an efficient and safe treatment option in experienced hands, regardless of the use of pulse modulation technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Urologic Surgery, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. friedrich.hartung@umm.de.
- Department of Urology and Urologic Surgery, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Förderung
- Medizinische Fakultät Mannheim der Universität Heidelberg
Zitieren
APA
Hartung, F. O., Egen, L., Gruene, B., Wenk, M. J., Kowalewski, K. F., Patroi, P., Rassweiler-Seyfried, M. C., Michel, M. S., & Herrmann, J. (2024). Pulse modulation in En-Bloc HoLEP: does it really matter? A propensity score matched analysis. World Journal of Urology. https://doi.org/10.1007/s00345-024-04830-8
Vancouver
Hartung FO, Egen L, Gruene B, Wenk MJ, Kowalewski KF, Patroi P, et al. Pulse modulation in En-Bloc HoLEP: does it really matter? A propensity score matched analysis. World Journal of Urology. 2024. doi:10.1007/s00345-024-04830-8
BibTeX
@article{Hartung2024,
author = {Hartung, Friedrich Otto and Egen, Luisa and Gruene, Britta and Wenk, Maren Juliane and Kowalewski, Karl-Friedrich and Patroi, Paul and Rassweiler-Seyfried, Marie-Claire and Michel, Maurice Stephan and Herrmann, Jonas},
title = {Pulse modulation in En-Bloc HoLEP: does it really matter? A propensity score matched analysis},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-04830-8}
}
EUVIMED